Clinical trial Recruiting at 1 site Interventional Ages 65 to 85

Wireless home prehabilitation for older adults with NSCLC awaiting lung surgery

Official title: Home-Based Prehabilitation Using Wireless Wearable Mobile Monitoring Devices for Elderly Patients With Non-Small Cell Lung Cancer

Run by West China Hospital · NCT07809763 · Data updated 2026-11-12

This study tests whether a personalized home exercise program guided by wearable devices can improve lung function for older NSCLC patients preparing for curative lung surgery.

More Non-small Cell Lung Cancer (NSCLC) trials

Quick facts

Study typeInterventional
Ages65 Years to 85 Years
SexAll
Enrollment196 (estimated)
SponsorWest China Hospital
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedSeptember 10, 2026
Main results expectedJuly 31, 2028
Study endsJuly 31, 2028
Registry record updatedSeptember 9, 2026
Trial IDNCT07809763 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 65–85 with NSCLC scheduled for elective curative lobectomy or segmentectomy, able to use a smartphone app and wearable devices, and with suitable ECOG/KPS status.

Probably not a fit

Patients who cannot engage with home monitoring tech, have unstable comorbidities, or do not complete the prehabilitation program may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized trial, patients aged 65–85 with NSCLC scheduled for curative lobectomy or segmentectomy receive a home-based prehabilitation program or standard perioperative care. The intervention uses wireless wearables and a smartphone app to monitor steps, heart rate, and oxygen saturation while delivering a tailored mix of aerobic, resistance, and inspiratory muscle exercises for 2–4 weeks before surgery and through 90 days after. Primary outcome is the difference in FEV1 percent predicted at 90 days post-surgery, adjusted for baseline, with several secondary endpoints including functional capacity, daily activity, hypoxemia measures, patient-reported quality of life, dyspnea, postoperative complications, and readmissions. The trial aims to determine safety and feasibility as well as potential improvements in recovery. Enrollment is restricted to older adults with adequate access to and ability to use the monitoring devices and app, under the care of West China Hospital in Chengdu, China.

Why it matters

Potential benefit: If successful, patients may experience better lung function and recovery after surgery, with potential reductions in complications and hospital readmissions.

How similar studies have gone: Previous studies in rehabilitation and perioperative optimization have shown trends toward improved function with home-based programs, but this exact wearable-guided prehabilitation approach is relatively novel in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥65 and ≤85 years
* Histopathologically confirmed primary non-small cell lung cancer (NSCLC), scheduled for elective curative-intent lobectomy or segmentectomy
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2, or Karnofsky Performance Status (KPS) score ≥70
* Planned admission for surgery within 2 months, and judged by the investigator to have stable disease suitable for participation in a home-based rehabilitation program
* Able to operate a smartphone application and wearable devices independently or with caregiver assistance
* Willing and able to provide written informed consent

Exclusion Criteria:

* Pre-existing long-term home oxygen therapy, or severe resting respiratory dysfunction
* Concurrent severe, uncontrolled cardiovascular disease, hepatic insufficiency, or renal insufficiency
* Other diseases that seriously affect motor function or compliance
* Known or suspected contact allergy to medical adhesives or materials used in the wearable devices
* Any other condition that, in the investigator's judgment, makes the subject unsuitable for participation

Where it's running

  • West China Hospital
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.